Refers to amount of adoption adjustment to accumulated deficit under ASC 606 incurred during the period.

No definition available.

Name:	mson_AdoptionAdjustmentToAccumulatedDeficitUnderAsc606
Namespace Prefix:	mson_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Description of beginning year of minimum royalty payments.

+ References

No definition available.

+ Details

Name:	mson_BeginningYearOfMinimumRoyaltyPayments
Namespace Prefix:	mson_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Refers to amount of longterm contract assets as on balance sheet date.

+ References

No definition available.

+ Details

Name:	mson_LongtermContractAssets
Namespace Prefix:	mson_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Refers to amount of minimum royalty payments incurred during the period.

+ References

No definition available.

+ Details

Name:	mson_MinimumRoyaltyPayments
Namespace Prefix:	mson_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Refers to amount of transfer initial payments of functional intellectual property incurred during the period.

+ References

No definition available.

+ Details

Name:	mson_TransferInitialPaymentsOfFunctionalIntellectualProperty
Namespace Prefix:	mson_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The amount of a reclassification adjustment made to prior period financial statement amounts.

+ References

No definition available.

+ Details

Name:	us-gaap_PriorPeriodReclassificationAdjustment
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1)
-URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

+ Details

Name:	us-gaap_Revenues
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Details

Name:	us-gaap_NewAccountingPronouncementEarlyAdoptionAxis=us-gaap_AdjustmentsForNewAccountingPrincipleEarlyAdoptionMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=mson_LicenseAndExclusiveManufacturingAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=mson_HunanXingHangRuiKangBioTechnologiesCoLtdMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Revenue Recognition (Details Narrative) - USD ($)			3 Months Ended		6 Months Ended
Revenue Recognition (Details Narrative) - USD ($)	Jul. 02, 2018	Oct. 19, 2017	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2018	Dec. 31, 2017	Jun. 30, 2018
Revenues			$ 10,176,453	$ 8,323,845	$ 19,537,617	$ 15,604,568
Adoption adjustment to accumulated deficit under ASC 606					960,000
Contract assets			$ 960,000		960,000		$ 0
Accounting Standards Codification 605 [Member]
Adoption adjustment to accumulated deficit under ASC 606					$ 960,000
License And Exclusive Manufacturing Agreement [Member]
Cumulative prior period adjustment	$ 960,000
License And Exclusive Manufacturing Agreement [Member] \| Hunan Xing Hang Rui Kang Bio-technologies Co Ltd [Member]
Transfer initial payments of functional intellectual property		$ 5,000,000
Minimum royalty payments		$ 2,000,000
Beginning year of minimum royalty payments		2019